ICAD INC. - COMMON STOCK

iCAD to Report Second Quarter 2021 Financial Results on Thursday, August 5

22 يوليو 2021 16:01:00 بحسب Nasdaq GlobeNewswire

iCAD’s ProFound AI for Digital Breast Tomosynthesis Version 3.0 Receives CE Mark Approval

14 يونيو 2021 08:00:01 بحسب Nasdaq GlobeNewswire

iCAD Signs Global Distribution Agreement with Sectra

08 يونيو 2021 08:00:01 بحسب Nasdaq GlobeNewswire

iCAD to Participate in Upcoming Virtual Investor Conferences

17 مايو 2021 16:05:01 بحسب Nasdaq GlobeNewswire

iCAD Announces Educational Webinar Featuring Leading Global Experts Discussing New Multidisciplinary Approach for Treating Brain Tumors, May 25

17 مايو 2021 08:00:02 بحسب Nasdaq GlobeNewswire

iCAD Reports Financial Results for First Quarter Ended March 31, 2021

28 أبريل 2021 16:01:00 بحسب Nasdaq GlobeNewswire

iCAD to Report First Quarter 2021 Financial Results on Wednesday, April 28

20 أبريل 2021 16:01:00 بحسب Nasdaq GlobeNewswire

New Research Confirms iCAD’s ProFound AI Aids Breast Cancer Detection with Digital Breast Tomosynthesis, Improves Radiologists’ Workflow

19 أبريل 2021 08:00:01 بحسب Nasdaq GlobeNewswire

iCAD Announces Estimated Q1 Revenues and Upcoming CFO Transition

05 أبريل 2021 16:01:00 بحسب Nasdaq GlobeNewswire

New Research Indicates ProFound AI May Reduce Interval Breast Cancer Rates

31 مارس 2021 08:00:01 بحسب Nasdaq GlobeNewswire

iCAD Announces FDA Clearance for ProFound AI Version 3.0 for 3D Mammography

15 مارس 2021 18:04:42 بحسب Nasdaq GlobeNewswire

New Research Supporting ProFound AI Presented at European Congress of Radiology Online Meeting

08 مارس 2021 12:36:23 بحسب Nasdaq GlobeNewswire

iCAD to Participate in the Cowen 41st Annual Health Care Conference

03 مارس 2021 21:16:22 بحسب Nasdaq GlobeNewswire

iCAD Announces Pricing of $22.0 Million Public Offering of Common Stock

03 مارس 2021 00:47:48 بحسب Nasdaq GlobeNewswire

iCAD Announces Proposed Public Offering of Common Stock

02 مارس 2021 16:01:00 بحسب Nasdaq GlobeNewswire

iCAD Reports Financial Results for Fourth Quarter and Year Ended December 31, 2020

24 فبراير 2021 16:01:01 بحسب Nasdaq GlobeNewswire

iCAD to Report Fourth Quarter 2020 Financial Results on Wednesday, February 24

18 فبراير 2021 18:56:26 بحسب Nasdaq GlobeNewswire

iCAD to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

16 فبراير 2021 16:01:00 بحسب Nasdaq GlobeNewswire

iCAD to Participate in B. Riley Securities Virtual Oncology Investor Conference

19 يناير 2021 08:00:02 بحسب Nasdaq GlobeNewswire

iCAD to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event

06 يناير 2021 16:01:00 بحسب Nasdaq GlobeNewswire